Intra-articular injections of platelet-rich plasma in symptomatic knee osteoarthritis: a consensus statement from French-speaking experts - Takeaways - MDSpire

Intra-articular injections of platelet-rich plasma in symptomatic knee osteoarthritis: a consensus statement from French-speaking experts

  • By

  • Florent Eymard

  • Paul Ornetti

  • Jérémy Maillet

  • Éric Noel

  • Philippe Adam

  • Virginie Legré-Boyer

  • Thierry Boyer

  • Fadoua Allali

  • Vincent Gremeaux

  • Jean-François Kaux

  • Karine Louati

  • Martin Lamontagne

  • Fabrice Michel

  • Pascal Richette

  • Hervé Bard

  • June 24, 2020

  • 0 min

Share

  • 1

    Platelet-rich plasma (PRP) injections are increasingly used for treating knee osteoarthritis, derived from autologous blood samples.

  • 2

    PRP contains numerous growth factors and anti-inflammatory mediators that may provide therapeutic effects in joint tissues.

  • 3

    International societies recommend against PRP use in knee osteoarthritis due to insufficient robust data on clinical efficacy.

  • 4

    A group of French-speaking experts was formed to create a consensus on PRP use in knee OA, addressing the heterogeneity in existing studies.

  • 5

    The consensus resulted in 25 recommendations aimed at standardizing PRP injection practices and improving clinical outcomes in knee OA.

Original Source(s)

Intra-articular injections of platelet-rich plasma in symptomatic knee osteoarthritis: a consensus statement from French-speaking experts

  • by Florent Eymard, Paul Ornetti, Jérémy Maillet, Éric Noel, Philippe Adam, Virginie Legré-Boyer, Thierry Boyer, Fadoua Allali, Vincent Gremeaux, Jean-François Kaux, Karine Louati, Martin Lamontagne, Fabrice Michel, Pascal Richette, Hervé Bard

  • June 24, 2020

Related Content

Obesity Not Associated With Worse Long-Term TAR Outcomes

A long-term cohort study found that obesity was not associated with worse patient-reported outcomes or higher reoperation rates following total ankle replacement in optimized surgical candidates.

Integrative multi-omics identifies MSR1 as a programmed cell death and extracellular matrix hub gene in osteoarthritis with hesperidin targeting potential

PT vs CBT for Chronic Low Back Pain

Sequential, multiple-assignment randomized trial compares stage I and stage II nonpharmacologic treatments over 52 weeks.